225 related articles for article (PubMed ID: 31022877)
1. Natural Product Mediated Regulation of Death Receptors and Intracellular Machinery: Fresh from the Pipeline about TRAIL-Mediated Signaling and Natural TRAIL Sensitizers.
Shahwar D; Iqbal MJ; Nisa MU; Todorovska M; Attar R; Sabitaliyevich UY; Farooqi AA; Ahmad A; Xu B
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022877
[TBL] [Abstract][Full Text] [Related]
2. Combined modality therapy with TRAIL or agonistic death receptor antibodies.
Amm HM; Oliver PG; Lee CH; Li Y; Buchsbaum DJ
Cancer Biol Ther; 2011 Mar; 11(5):431-49. PubMed ID: 21263219
[TBL] [Abstract][Full Text] [Related]
3. TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies.
Holoch PA; Griffith TS
Eur J Pharmacol; 2009 Dec; 625(1-3):63-72. PubMed ID: 19836385
[TBL] [Abstract][Full Text] [Related]
4. TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling.
Guerrache A; Micheau O
Cells; 2024 Mar; 13(6):. PubMed ID: 38534365
[TBL] [Abstract][Full Text] [Related]
5. Using natural products to promote caspase-8-dependent cancer cell death.
Tewary P; Gunatilaka AA; Sayers TJ
Cancer Immunol Immunother; 2017 Feb; 66(2):223-231. PubMed ID: 27286684
[TBL] [Abstract][Full Text] [Related]
6. MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists.
Espinosa-Gil S; Ivanova S; Alari-Pahissa E; Denizli M; Villafranca-Magdalena B; Viñas-Casas M; Bolinaga-Ayala I; Gámez-García A; Faundez-Vidiella C; Colas E; Lopez-Botet M; Zorzano A; Lizcano JM
Cell Death Dis; 2023 Nov; 14(11):715. PubMed ID: 37919293
[TBL] [Abstract][Full Text] [Related]
7. Death receptors as targets in cancer.
Micheau O; Shirley S; Dufour F
Br J Pharmacol; 2013 Aug; 169(8):1723-44. PubMed ID: 23638798
[TBL] [Abstract][Full Text] [Related]
8. On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics.
Dimberg LY; Anderson CK; Camidge R; Behbakht K; Thorburn A; Ford HL
Oncogene; 2013 Mar; 32(11):1341-50. PubMed ID: 22580613
[TBL] [Abstract][Full Text] [Related]
9. TRAIL-induced apoptosis and proteasomal activity - Mechanisms, signalling and interplay.
Boccellato C; Rehm M
Biochim Biophys Acta Mol Cell Res; 2024 Apr; 1871(4):119688. PubMed ID: 38368955
[TBL] [Abstract][Full Text] [Related]
10. The MUDENG Augmentation: A Genesis in Anti-Cancer Therapy?
Muthu M; Chun S; Gopal J; Park GS; Nile A; Shin J; Shin J; Kim TH; Oh JW
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759789
[TBL] [Abstract][Full Text] [Related]
11. Membrane trafficking of death receptors: implications on signalling.
Schneider-Brachert W; Heigl U; Ehrenschwender M
Int J Mol Sci; 2013 Jul; 14(7):14475-503. PubMed ID: 23852022
[TBL] [Abstract][Full Text] [Related]
12. Death receptor-ligand systems in cancer, cell death, and inflammation.
Walczak H
Cold Spring Harb Perspect Biol; 2013 May; 5(5):a008698. PubMed ID: 23637280
[TBL] [Abstract][Full Text] [Related]
13. A review on the impact of TRAIL on cancer signaling and targeting via phytochemicals for possible cancer therapy.
Govindasamy B; Muthu M; Gopal J; Chun S
Int J Biol Macromol; 2023 Dec; 253(Pt 5):127162. PubMed ID: 37788732
[TBL] [Abstract][Full Text] [Related]
14. TRAIL receptor-induced features of epithelial-to-mesenchymal transition increase tumour phenotypic heterogeneity: potential cell survival mechanisms.
Peyre L; Meyer M; Hofman P; Roux J
Br J Cancer; 2021 Jan; 124(1):91-101. PubMed ID: 33257838
[TBL] [Abstract][Full Text] [Related]
15. Surviving apoptosis: life-death signaling in single cells.
Flusberg DA; Sorger PK
Trends Cell Biol; 2015 Aug; 25(8):446-58. PubMed ID: 25920803
[TBL] [Abstract][Full Text] [Related]
16. Intracellular-signaling tumor-regression modeling of the pro-apoptotic receptor agonists dulanermin and conatumumab.
Kay BP; Hsu CP; Lu JF; Sun YN; Bai S; Xin Y; D'Argenio DZ
J Pharmacokinet Pharmacodyn; 2012 Oct; 39(5):577-90. PubMed ID: 22932917
[TBL] [Abstract][Full Text] [Related]
17. Death receptors as targets for anti-cancer therapy.
Papenfuss K; Cordier SM; Walczak H
J Cell Mol Med; 2008 Dec; 12(6B):2566-85. PubMed ID: 19210756
[TBL] [Abstract][Full Text] [Related]
18. Cancer and necroptosis: friend or foe?
Philipp S; Sosna J; Adam D
Cell Mol Life Sci; 2016 Jun; 73(11-12):2183-93. PubMed ID: 27048810
[TBL] [Abstract][Full Text] [Related]
19. Control of death receptor ligand activity by posttranslational modifications.
Weinlich R; Brunner T; Amarante-Mendes GP
Cell Mol Life Sci; 2010 May; 67(10):1631-42. PubMed ID: 20306114
[TBL] [Abstract][Full Text] [Related]
20. Dependence receptors: new targets for cancer therapy.
Brisset M; Grandin M; Bernet A; Mehlen P; Hollande F
EMBO Mol Med; 2021 Nov; 13(11):e14495. PubMed ID: 34542930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
